Rhostatin

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameRhostatin
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionRho-associated kinases inhibitors
TargetsRho-associated kinases
Therapy Area/IndicationsSolid tumoursBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioaxone
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioaxone
Active IndicationsN/A
Inactive IndicationsSolid tumoursBrain Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A